Brain volume loss and physical and cognitive impairment in naïve multiple sclerosis patients treated with fingolimod: prospective cohort study in Buenos Aires, Argentina

BACKGROUND: The percentage of brain volume loss (PBVL) has been classically considered as a biomarker in multiple sclerosis (MS). OBJECTIVE: The objective of the present study was to analyze if the PBVL during the 1(st) year after the onset of the disease predicts physical and cognitive impairment (...

Descripción completa

Detalles Bibliográficos
Autores principales: Rojas, Juan Ignacio, Patrucco, Liliana, Pappolla, Agustín, Sánchez, Francisco, Cristiano, Edgardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academia Brasileira de Neurologia - ABNEURO 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685825/
https://www.ncbi.nlm.nih.gov/pubmed/36254442
http://dx.doi.org/10.1055/s-0042-1755277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685825/
https://www.ncbi.nlm.nih.gov/pubmed/36254442
http://dx.doi.org/10.1055/s-0042-1755277

Ejemplares similares